Medtronic: Big plans in 2021
Medtronic (NYSE:MDT) meanwhile continues to work on its new Hugo system that is meant to rival Intuitive Surgical’s da Vinci robots. CEO Geoff Martha announced during an earnings call today that the company is on track to file for a CE Mark and U.S. IDE approval next month.“We feel really great about our platform, the feedback we’ve got, the open console, the modularity upgrade, ability to leverage of our surgical instrumentation,” Medical Surgical EVP and President Bob White said during the earnings call.
Titan Medical (TSX:TMD;NSDQ:TMDI) has an agreement with Medtronic to progress the development of robot-assisted surgical technologies.
In the orthopedics space, Medtronic is looking to add enhancements to its Mazor X spinal robotic system.